Fredrik Wermeling

Has grant

Associate Professor

Karolinska Institutet

Sweden

Research Interests

Explore related searches

Professors in Sweden Professors in Immunology Immunology professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

STUDIES OF NEUTROPHILS IN AUTOIMMUNE JOINT INFLAMMATION

Open Date: 2021-01-01

Close Date: 2024-01-01

Grant: Close

IL-4 based cancer immunotherapy

Open Date: 2020-01-01

Close Date: 2023-01-01

Grant: Close

CRISPR-based studies of pathogenic neutrophil biology

Open Date: 2018-01-01

Close Date:

Grant: Close

Swedish Rheumatism Association (Reumatikerförbundet)

Open Date:

Close Date:

Grant: Close

Börje Dahlin Foundation

Open Date:

Close Date:

Articles (10)

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (7)

Bernhard Schmierer

Head of CRISPR Functional Genomic

Karolinska Institutet

SWEDEN

View details

Zsolt Kasza

Karolinska Institutet

SWEDEN

View details

Renata Stripecke

Full professor/ Chair

University of Cologne

GERMANY

View details

Gustaf Wigerblad

National Institutes of Health

UNITED STATES

View details

Christina Elisabeth Gerstner

Karolinska Institutet

SWEDEN

View details

Yunbing Shen

Karolinska Institutet

SWEDEN

View details

Andre Ortlieb Guerreiro-Cacais

Karolinska University Hospital

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Fredrik Wermeling

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies

Modulating T-cell activation with antisense oligonucleotides targeting lymphocyte cytosolic protein 2.

A CRISPR-p53 interactome with potential implications for clinical CRISPR/Cas9 use.

A rapid CRISPR competitive assay for in vitro and in vivo discovery of potential drug targets affecting the hematopoietic system

In Vivo Lentiviral Gene Delivery of HLA-DR and Vaccination of Humanized Mice for Improving the Human T and B Cell Immune Reconstitution.

<i>In vitro</i> and <i>ex vitro</i> functional characterization of human HLA-DRB1∗04 restricted T cell receptors.

Biased TCR gene usage in citrullinated Tenascin C specific T-cells in rheumatoid arthritis

IL-4 controls activated neutrophil FcγR2b expression and migration into inflamed joints

Identifying novel B-cell targets for chronic inflammatory autoimmune disease by screening of chemical probes in a patient-derived cell assay.

Designing custom CRISPR libraries for hypothesis-driven drug target discovery

Collaborators (7)

Bernhard Schmierer

Zsolt Kasza

Renata Stripecke

Gustaf Wigerblad

Christina Elisabeth Gerstner

Yunbing Shen

Andre Ortlieb Guerreiro-Cacais

Make your next move.